Phanicare Pharmaceuticals

Hyderabad, India Founded: 2018 • Age: 8 yrs
Provides essential intermediates for pharmaceutical manufacturing with quality focus.

About Phanicare Pharmaceuticals

Phanicare Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2018. It provides essential intermediates for pharmaceutical manufacturing with quality focus. It operates on a B2B model. The company has 1 employees. Its Indian entity Phanicare Pharmaceuticals Private Limited reported revenue of β‚Ή41.70 Cr. Phanicare Pharmaceuticals offers products and services including Triphenyl Phosphine (TPP) and Pharmaceutical Intermediates. Its focus areas include Life Sciences, Intermediates Manufacturing, Essential Chemicals and Chemicals. Its competitors include Viyash, Inventys and Blue Jet Healthcare; 2 of its 3 listed competitors have raised funding.

Company details

Phanicare Pharmaceuticals Private Limited, based in Hyderabad, India, specializes in supplying pharmaceutical intermediates like Triphenyl Phosphine (TPP). They source and deliver cost-efficient products to manufacturers worldwide, emphasizing quality standards and competitive pricing. The company maintains close customer liaison to meet needs and supports supply chains through innovative solutions, ensuring continual improvement in operations.

Key Metrics
  • Annual Revenue
    ₹41.70 Cr

    FY 2024 · -18% YoY

  • Net Profit
    ₹53.3 Lakh

    FY 2024 · 1% margin

  • EBITDA
    ₹3.13 Cr

    FY 2024 · 8% margin

  • Employee Count
    1

Products & Services of Phanicare Pharmaceuticals

Phanicare Pharmaceuticals offers a comprehensive portfolio of products and services, including Triphenyl Phosphine (TPP) and Pharmaceutical Intermediates.

Triphenyl Phosphine (TPP)
Pharmaceutical Intermediate

Chemical compound used for drug synthesis in manufacturing.

Pharmaceutical Intermediates
Chemical Supplies

Various essentials for pharmaceutical production and applications.

Board of directors of Phanicare Pharmaceuticals Private Limited (Phanicare Pharmaceuticals)

Phanicare Pharmaceuticals Private Limited is the primary company behind Phanicare Pharmaceuticals. The board of Phanicare Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Vishnuvardhan Reddy Devireddy, appointed in 2015. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vishnuvardhan Reddy Devireddy
DIN 01687398
Director08 Apr 201511 yrs 6 moPhanicare Pharmaceuticals Private Limited
Mallikarjuna Reddy Venati
DIN 01687544
Director08 Apr 201511 yrs 6 moPhanicare Pharmaceuticals Private Limited
Padma Duvvuri
DIN 01687434
Director21 Apr 201610 yrs 6 moPhanicare Pharmaceuticals Private Limited
Sumanth Karlapudi
DIN 09188185
Director01 Oct 20224 yrsPhanicare Pharmaceuticals Private Limited

Financials of Phanicare Pharmaceuticals

Figures of Phanicare Pharmaceuticals Private Limited, the primary company behind Phanicare Pharmaceuticals, for FY 2024. Revenue was ₹41.70 Cr (-18% year on year). Net profit was ₹53.3 Lakh (1% margin). EBITDA was ₹3.13 Cr (8% margin). Revenue has grown at a compounded annual rate of +19% over three years and +18% over five years.

  • ₹41.70 CrRevenue · FY 2024 · -18% YoY
  • ₹53.3 LakhNet profit · 1% margin
  • ₹3.13 CrEBITDA · 8% margin
  • ₹3.30 CrPaid-up capital
  • 1Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Phanicare Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Phanicare Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Phanicare Pharmaceuticals

Phanicare Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Viyash, Inventys and Blue Jet Healthcare.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
viyash.com2019Hyderabad, India$120.02M277
APIs and intermediates are manufactured by Viyash as a CDMO.
inventys.in2005Mumbai, India$64.34M219
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
bluejethealthcare.com1969Mumbai, India476
CDMO focused on manufacturing, supplier, and development of intermediates & APIs
Premium access

Detailed competitors of Phanicare Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Phanicare Pharmaceuticals

Phanicare Pharmaceuticals was founded in 2018.

Phanicare Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Phanicare Pharmaceuticals has 1 employees.

The primary company behind Phanicare Pharmaceuticals, Phanicare Pharmaceuticals Private Limited, reported revenue of β‚Ή41.70 Cr for FY 2024, down 18% year on year.

Phanicare Pharmaceuticals Private Limited, based in Hyderabad, India, specializes in supplying pharmaceutical intermediates like Triphenyl Phosphine (TPP). They source and deliver cost-efficient products to manufacturers worldwide, emphasizing quality standards and competitive pricing. The company maintains close customer liaison to meet needs and supports supply chains through innovative solutions, ensuring continual improvement in operations.

Phanicare Pharmaceuticals's top competitors include Inventys, Viyash and Blue Jet Healthcare.

Phanicare Pharmaceuticals offers Triphenyl Phosphine (TPP) and Pharmaceutical Intermediates.

Phanicare Pharmaceuticals operates through Phanicare Pharmaceuticals Private Limited.

The legal entities of Phanicare Pharmaceuticals currently have 4 directors, including Sumanth Karlapudi, Vishnuvardhan Reddy Devireddy, Mallikarjuna Reddy Venati and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available